Skip to main content
Synthetic DNA

Synthetic DNA production for cutting-edge biotechnology solutions.

Synthetic DNA has become a critical component of a wide range of emerging and established industries with global demand increasing rapidly. Current approaches are unable to keep up with the quantity, quality and complexity required for cutting-edge technologies.

The current production model cannot deliver the future demand for DNA.

Navigate to the next section
Services

Whether it is custom synthesis, contract research into new compounds or material supply, you can rely on our experienced multidisciplined team to deliver the best solutions tailored to your specific needs.

NunaBio Range of Services.

Material Supply

We supply high quality and affordable DNA for a wide range of industries.

Contract Research

We will carry out all the necessary research needed for the development of your unique target products.

Custom Synthesis

Advanced and reliable DNA synthesis covering any length or complexity.

Process Improvement

Our work is fully documented and a package of data and specifications can be assembled to allow scale up manufacture to start smoothly.

Rapid Design Iteration

We work through detail design, integration, and initial testing, repeating this process to optimise the design before verification testing.
Navigate to the next section
Features
NunaBio Service Features.

Short Oligonucleotides.

Customised DNA oligos according to your specifications. We offer a range of purification options and scales.

Closed-ended DNA.

Linear, double stranded and covalently closed DNA constructs of a range of lengths and scales.

A Range of Modifications.

Pre-made building blocks & in-house expertise: We have the labelled nucleotides you need.

Repetitive Sequences.

Homologous DNA fragments with a range of repeating unit lengths and multiple spacer sequences available.

Long Genes/Gene Fragments.

Genes and gene fragments suited for a variety of workflows and applications including protein evolution, gene construction, antibody engineering, and more.

Homopolymers.

Consecutive identical bases as part of a given sequence or individual constructs.
Get in touch
Navigate to the next section
Technology

Our multi-patented technology produces synthetic DNA using enzymes rather than hazardous chemicals.

NunaBio Product Benefits.

  • High purity

  • Scaleable

  • Fast turnaround

  • Cell-free

  • Complex sequences

  • Low cost

Navigate to the next section
Market

NunaBio serves a Total Addressable Market as a service provider and platform manufacturer.

Reagents.

7
by 2026
Penetrated Market
Global microarray market
to reach $7.4bn by 2026

Biosensors.

36
by 2026
Target Market
Global market to reach
$36.7bn by 2026

Synthetic Biology.

30
by 2026
Qualified Available
Global gene synthesis biology
market to reach $30.7bn by 2026

Gene Therapies.

21
by 2026
Available Market
Global gene therapy market
expected to reach $21.2bn by 2026

Vaccines.

142
by 2026
Available Market
Global vaccine market
expected to reach $142.2bn by 2026

Technology

Our core technology is extremely versatile and can also be applied to a wide range of adjacent markets.

About Us
Navigate to the next section

About

Learn more about NunaBio.

Careers

Working with NunaBio.

News

Keep up to date with NunaBio.

Contact

Get in touch with NunaBio.

NunaBio Ltd
The Biosphere
Draymans Way
Newcastle Helix
Newcastle upon Tyne
NE4 5BX

T.+44 (0) 330 2292700
info@nunabio.com

Manage Cookie Consent

Privacy Policy
Quality Policy